Tenders
Insulin tenders in Czechia
Insulin tenders in Czechia: 184 listed on GranTender since 2024. The median awarded contract value is about €31,000 (380 contracts with a stated value). Buyers with the most tenders: Fakultní nemocnice Bulovka (91), Institut klinické a experimentální medicíny (22) and Fakultní nemocnice Olomouc (12); suppliers with the most contract awards: ViaPharma s.r.o. (37), Avenier a.s. (22) and Boehringer Ingelheim, spol. s r.o. (12). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €33,000; 59% of contracts drew a single bid (1.6 bids on average). Data as of 18 November 2026; updated daily.
- Tenders
- 184
- Open tenders
- 0
- Awards
- 547
- Awarded value awarded
- €98,772,331
- Awarded value contract
- €30,391,737
- Awarded value framework ceiling
- €18,661,620
- Median contract value awarded
- ≈ €31,000
- Median contract value contract
- ≈ €150,000
- Median contract value framework ceiling
- ≈ €240,000
- Average bids per contract
- 2.2
- Tenders in 2025
- 100 +117% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
No records yet.
Latest tenders
| Tender | Buyer | Estimated value | Status | Published |
|---|---|---|---|---|
| Kupní smlouva na Dodávky zdravotnických prostředků - senzory pro monitotaci glykémie, část č.3 -Kominikace s inzulínovou pumpou C- Komunikace s inzulínovou pumpou C | Institut klinické a experimentální medicíny | — | Awarded | 16 October 2026 |
| Antidiabetika - inzulíny a kombinace XI. - Tresiba | Institut klinické a experimentální medicíny | CZK 24,000,000 (≈ €987,817) | Awarded | 19 August 2026 |
| Léčivé přípravky s obsahem semaglutidu | Fakultní nemocnice Hradec Králové | CZK 1,563,150 (≈ €64,338) | Awarded | 23 July 2026 |
| Léčivé přípravky s obsahem semaglutidu | Fakultní nemocnice Hradec Králové | CZK 1,563,150 (≈ €64,338) | Awarded | 23 July 2026 |
| METFORMIN A DAPAGLIFLOZIN 2026 | Fakultní nemocnice Olomouc | — | Awarded | 22 July 2026 |
| Léčivé přípravky s obsahem semaglutidu | Fakultní nemocnice Hradec Králové | — | Awarded | 22 July 2026 |
| Léčivé přípravky s obsahem insulinů a jejich analog II. | Fakultní nemocnice Hradec Králové | CZK 26,104,710 (≈ €1,074,445) | Awarded | 18 May 2026 |
| Léčivé přípravky s obsahem insulinů a jejich analog II. | Fakultní nemocnice Hradec Králové | CZK 26,104,710 (≈ €1,074,445) | Awarded | 18 May 2026 |
| Léčivé přípravky s obsahem insulinů a jejich analog II. | Fakultní nemocnice Hradec Králové | — | Awarded | 14 May 2026 |
| LP s obsahem tirzepatidu 2026 | Fakultní nemocnice Olomouc | CZK 7,913,081 (≈ €325,695) | Awarded | 30 March 2026 |
| Antidiabetika - inzulíny a kombinace X. | Institut klinické a experimentální medicíny | CZK 44,800,000 (≈ €1,843,925) | Awarded | 16 March 2026 |
| Antidiabetika - inzulíny a kombinace X. | Institut klinické a experimentální medicíny | CZK 44,800,000 (≈ €1,843,925) | Awarded | 12 March 2026 |
| Léčivé přípravky s obsahem semaglutidu a tirzepatidu | Fakultní nemocnice Hradec Králové | CZK 63,980,060 (≈ €2,633,358) | Awarded | 9 March 2026 |
| Léčivé přípravky s obsahem semaglutidu a tirzepatidu | Fakultní nemocnice Hradec Králové | CZK 63,980,060 (≈ €2,633,358) | Awarded | 9 March 2026 |
| Léčivé přípravky s obsahem semaglutidu a tirzepatidu | Fakultní nemocnice Hradec Králové | — | Awarded | 6 March 2026 |
| Léčivé přípravky s obsahem semaglutidu a tirzepatidu | Fakultní nemocnice Hradec Králové | CZK 63,980,060 (≈ €2,633,358) | Closed | 5 March 2026 |
| Léčivé přípravky s obsahem semaglutidu a tirzepatidu | Fakultní nemocnice Hradec Králové | CZK 63,980,060 (≈ €2,633,358) | Closed | 5 March 2026 |
| Léčivé přípravky s obsahem insulinů a jejich analog | Fakultní nemocnice Hradec Králové | CZK 7,571,480 (≈ €311,635) | Awarded | 23 February 2026 |
| Léčivé přípravky s obsahem insulinů a jejich analog | Fakultní nemocnice Hradec Králové | CZK 7,571,480 (≈ €311,635) | Awarded | 23 February 2026 |
| Léčivé přípravky s obsahem insulinů a jejich analog | Fakultní nemocnice Hradec Králové | — | Awarded | 20 February 2026 |
Top buyers
- Fakultní nemocnice Bulovka91
- Institut klinické a experimentální medicíny22
- Fakultní nemocnice Olomouc12
- Fakultní Thomayerova nemocnice6
- Karlovarská krajská nemocnice a.s.1
- Nemocnice Nymburk s.r.o.1
- Nemocnice Pardubického kraje, a.s.1
- Nemocnice s poliklinikou Česká Lípa, a.s.1
- Nemocnice Znojmo, příspěvková organizace1
Top winners
Competition and prices
In 2025, half of the contracts were worth between €12,000 and €87,000, with a median of €33,000 (161 contracts with a stated awarded value). Contracts drew 1.6 bids on average (median 1) and 59% drew a single bid — based on 207 contracts with a known number of bids. Compared with 2024, in 2025 the median value fell 82% and the share of single-bid contracts fell from 64% to 59%. The usual procedures: other procedures (60%), open procedure (39%), restricted procedure (1%) — of 146 tenders with a stated procedure.
The most contracts went to ViaPharma s.r.o. (37), Avenier a.s. (22) and Boehringer Ingelheim, spol. s r.o. (12) — together 13% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2024 | 106 | €180,000 (contract value) | €87,000 – €370,000 | 5.6 | 64% (70) |
| 2025 | 222 | €33,000 | €12,000 – €87,000 | 1.6 | 59% (207) |
| 2026 (so far) | 216 | €24,000 | €13,000 – €69,000 | 1.6 | 58% (207) |
| All years | 544 | €31,000 | €14,000 – €100,000 | 2.2 | 59% (484) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 59% of the 440 contracts with a known number of bids had a single bid; the median was 1 bid. The number of bids is known for 440 of the 464 contracts from procedures with competition.
Buyers who often get few offers
The buyers below usually received one or two offers per contract — an offer from you would stand out.
| Buyer | Contracts with known bids | Median bids | Single bid |
|---|---|---|---|
| Fakultní nemocnice Bulovka | 364 | 1 | 65% |
| Institut klinické a experimentální medicíny | 12 | 2 | 25% |
| Fakultní nemocnice Olomouc | 7 | 1 | 57% |
In the last 12 months, 0 companies won their first contract in our records here — 0% of the 44 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Insulin and antidiabetic drugs in neighbouring countries
Today, 7 tenders in the same niche are open in neighbouring countries.
- Germany — 6 open today · how to bid in Germany
- Poland — 1 open today · how to bid in Poland
Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.
Expected soon1
| Expected | Buyer | What | Why we expect it | Confidence |
|---|---|---|---|---|
| Apr – Sep 2027 | Fakultní nemocnice Bulovka | Insulin and antidiabetic drugs | The current contract with Avenier a.s. ends on 15 October 2027 (from its stated duration); no new tender has been published yet. | high |
Forecast from public data, not an announcement. Methodology.
Market reports
Insulin and antidiabetic drugs by city
Insulin and antidiabetic drugs in other countries
Insulin and antidiabetic drugs across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Where can I find insulin tenders in Czechia?
- GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most insulin tenders in Czechia?
- By number of contracts won: ViaPharma s.r.o. (37), Avenier a.s. (22), Boehringer Ingelheim, spol. s r.o. (12).
- Which buyers publish the most insulin tenders in Czechia?
- By number of tenders: Fakultní nemocnice Bulovka (91), Institut klinické a experimentální medicíny (22), Fakultní nemocnice Olomouc (12).
- Which CPV codes belong to “Insulin and antidiabetic drugs”?
- 33615000 Medicinal products used in diabetes; plus tenders without a usable CPV code whose title names the topic.
- How many bids do insulin tenders in Czechia receive on average?
- In 2025, contracts drew 1.6 bids on average (median 1) and 59% drew a single bid — based on 207 contracts with a known number of bids.
- How much are contracts for insulin tenders in Czechia worth?
- In 2025, half of the contracts were worth between €12,000 and €87,000, with a median of €33,000 (161 contracts with a stated awarded value). Compared with 2024, in 2025 the median value fell 82% and the share of single-bid contracts fell from 64% to 59%.
- Which procedures are used for insulin tenders in Czechia?
- The usual procedures: other procedures (60%), open procedure (39%), restricted procedure (1%) — of 146 tenders with a stated procedure.
- Which buyers get few offers in insulin tenders in Czechia?
- Since 1 November 2024, these buyers usually received one or two offers per contract: Fakultní nemocnice Bulovka (median 1 bid over 364 contracts), Institut klinické a experimentální medicíny (median 2 bids over 12 contracts) and Fakultní nemocnice Olomouc (median 1 bid over 7 contracts). Since 1 November 2024, 59% of the 440 contracts with a known number of bids had a single bid; the median was 1 bid.
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.